Funded Startups in New Haven
Among the 29 most recent funded entries tied to New Haven, the largest disclosed round is VeraDermics’ $150M (Series C) on 2025-10-16; every other disclose…
Among the 29 most recent funded entries tied to New Haven, the largest disclosed round is VeraDermics’ $150M (Series C) on 2025-10-16; every other disclosed amount below that stays under $302M (Biohaven Pharmaceutical’s $302M is higher but is an older row), and the list is otherwise dominated by mid-ticket raises such as Wavelet Medical’s $2M (2026-06-16) and Quantum Circuits’ $27M (2024-05-01). Temporal clustering is visible: 6 of the 29 rows fall between 2024-09-03 and 2025-04-07 (e.g., Oxylus Energy $5M on 2024-09-03; VeraDermics $150M on 2025-10-16 is later, but several 2024-09 to 2025-04 rounds are concentrated), while the earliest shown dates back to 2020-06-25 with Simcha Therapeutics. The stage/label mix leans heavily into unspecified disclosure: 12 of 29 rows are marked “Series Unknown” or blank, and “undisclosed” appears on 3 rows (e.g., Arvinas on 2025-08-15; DeepLook Medical on 2024-09-18). Sector-wise, biotech repeats across the list (e.g., VeraDermics, Seranova Bio, Ikonisys, Revmedica, Osmol Therapeutics), but healthcare also shows up frequently, with multiple disclosed rounds from Health Care companies between 2022 and 2026.
Most recent rounds
29 shownRelated listings
Frequently asked
What stands out on deal size, and how extreme is the top round versus the rest?
The largest disclosed round in these rows is Biohaven Pharmaceutical’s $302M on 2022-10-20, with VeraDermics at $150M on 2025-10-16 as the next-largest disclosed amount. Outside that top tier, many disclosed rounds cluster well below $30M (for example, Wavelet Medical $2M on 2026-06-16; Peer Robotics $5M on 2026-01-05), and several entries are small or even $30K (Floe on 2025-03-17).
Are there any time windows where multiple funded rounds land close together?
Yes. Several rounds concentrate in the 2024-09 to 2025-04 window, including Oxylus Energy $5M (2024-09-03), Log Still Distillery $750K (2024-09-04), DeepLook Medical (undisclosed) on 2024-09-18, and D2B3 $500K (2025-04-07). The list also spans a broader edge-to-edge period from 2020-06-25 (Simcha Therapeutics) to the most recent 2026-06-16 (Wavelet Medical).
Which sectors are most represented, based on recurring entries?
Biotechnology appears repeatedly across the rows (e.g., VeraDermics 2025-10-16 $150M; Seranova Bio 2024-02-01 $10M; Ikonisys 2023-06-15 $540K; Osmol Therapeutics 2022-04-12 $5M; Cybrexa Therapeutics 2021-03-10 $25M). Healthcare is also a frequent label (Wavelet Medical 2026-06-16 $2M; Revmedica 2023-06-14 $14M; DeepLook Medical 2024-09-18 undisclosed).
How much of the list has incomplete stage/amount disclosure, and does it affect comparisons?
Stage labels are often unspecified: 12 of 29 rows are marked “Series Unknown” or blank (e.g., Wavelet Medical on 2026-06-16; BioXcel Therapeutics on 2026-03-10; Arvinas on 2025-08-15 has Series Unknown). Amounts are also missing on 3 rows marked “undisclosed” (Arvinas 2025-08-15; DeepLook Medical 2024-09-18; Greater New England Minority Supplier Development Council 2022-04-05).
Are there geography mismatches or edge cases in the “New Haven” labeling?
Most rows list New Haven, Connecticut, but one entry is outside that exact geography: Log Still Distillery is shown as New Haven, Kentucky (Seed $750K on 2024-09-04). A second edge case is Allyx Therapeutics, listed as New Haven, New York, with no stage label and $8M on 2021-06-01.
Which stage labels show up most often, and where are the major disclosed rounds outside typical stages?
Beyond “Series Unknown/blank” dominance, specific stage callouts include high-value outliers like VeraDermics’ Series C $150M (2025-10-16) and Biohaven Pharmaceutical’s Post-IPO Equity $302M (2022-10-20). Smaller disclosed seed/pre-seed examples appear as well, such as D2B3 Pre-Seed $500K (2025-04-07) and Oxylus Energy Seed $5M (2024-09-03), indicating a wide stage range even within a single city-focused slice.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.